Table 1.
Descriptive statistics (N=12).
| Variable | Values | |
| Age (years), mean (SD) | 65.3 (6.2) | |
| Sex, n (%) | ||
|
|
Female | 5 (42) |
|
|
Male | 7 (58) |
| Primary diagnosis, n (%) | ||
|
|
Lung adenocarcinoma | 10 (83) |
|
|
Lung squamous cell carcinoma | 2 (17) |
| Stage, n (%) | ||
|
|
Ⅰ | 1 (8) |
|
|
Ⅲ | 2 (17) |
|
|
Ⅳ | 9 (75) |
| Treatment, n (%) | ||
|
|
Target (EGFR-TKIa) | 9 (75) |
|
|
Chemotherapy | 3 (25) |
| Cardiovascular drugs, n (%) | ||
|
|
No | 6 (50) |
|
|
Yes | 6 (50) |
| Hypnotics, n (%) | ||
|
|
No | 10 (83) |
|
|
Yes | 2 (17) |
| ECOGb, n (%) | ||
|
|
1 | 9 (75) |
|
|
2 | 3 (25) |
aEGFR-TKI: epidermal growth factor receptor–tyrosine kinase inhibitor.
bECOG: Eastern Cooperative Oncology Group Performance Status.